Efficacy of Myofascial Induction as a Manual Therapy Technique in Patients With Anxiety
1 other identifier
interventional
36
1 country
1
Brief Summary
This study evaluates the efficacy of a myofascial intervention as a technique within manual therapy in the treatment of clinical anxiety in adults. Half of the participants will receive a myofascial intervention program, while the other half will receive a sham myofascial intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable anxiety
Started Apr 2021
Typical duration for not_applicable anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 25, 2021
CompletedFirst Posted
Study publicly available on registry
April 1, 2021
CompletedStudy Start
First participant enrolled
April 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 29, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 29, 2022
CompletedAugust 2, 2022
July 1, 2022
1.3 years
March 25, 2021
July 31, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
State-Trait Anxiety Inventory (STAI)
It consists of a self-report to evaluate two independent concepts about anxiety: anxiety as a state ("in this moment") and anxiety as a trait ("in most cases"). Each of these subscales has a total of 20 items in a 4-point Likert response system according to intensity (0 = not at all; 3 = a lot). The total score in each of the subscales ranges from 0 to 60 points.
Change from baseline (pre-treatment), immediately after myofascial intervention (intrasession), through study completion (an average of 1 month), 3 and 6 months follow-up
Secondary Outcomes (5)
Visual Analogue Scale (VAS)
Change from baseline (pre-treatment), immediately after myofascial intervention (intrasession), through study completion (an average of 1 month), 3 and 6 months follow-up
Central Sensitization Inventory (CSI)
Change from baseline (pre-treatment), through study completion (an average of 1 month), 3 and 6 months follow-up
General Health Questionnaire (GHQ-12)
Change from baseline (pre-treatment), through study completion (an average of 1 month), 3 and 6 months follow-up
Patient Health Questionnaire (PHQ-15)
Change from baseline (pre-treatment), through study completion (an average of 1 month), 3 and 6 months follow-up
Beck Depression Inventory (BDI)
Change from baseline (pre-treatment), through study completion (an average of 1 month), 3 and 6 months follow-up
Study Arms (2)
Myofascial treatment
EXPERIMENTAL4 sessions of myofascial intervention, 40 minutes per session, 1 session per week
Sham myofascial treatment
SHAM COMPARATOR4 sessions of sham myofascial intervention, 40 minutes per session, 1 session per week
Interventions
40 minutes of myofascial intervention: 10 min in each of the following regions with the patient face up: * Thoracolumbar fascia and abdomen * C7-T4 and sternum * Suboccipital area * Temporary area
40 minutes of sham myofascial intervention: 10 min in each of the following regions with the patient face up and with the contact of the physiotherapist through a towel and without any intention: * Thoracolumbar fascia and abdomen * C7-T4 and sternum * Suboccipital area * Temporary area
Eligibility Criteria
You may qualify if:
- Be between 18 and 65 years old
- Subjects with high levels of anxiety
- Subjects who speak and understand Spanish correctly
- Subjects without previous experience in myofascial treatment
You may not qualify if:
- Subjects with a clinical history of cognitive impairment
- Subjects with systemic, neurological or muscular diseases
- Subjects with some type of aneurysm diagnosed
- Subjects with diagnosed extremely high blood pressure
- Subjects with diagnosed malignant tumors
- Subjects with diagnosed vertebrobasilar insufficiency
- Subjects with a diagnosed dermatological condition
- Subjects diagnosed with epilepsy
- Pregnant women or with the possibility that they may be
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pulsion Fisioterapia
Madrid, 28028, Spain
Related Publications (1)
Gozalo-Pascual R, Gonzalez-Ordi H, Atin-Arratibel MA, Llames-Sanchez J, Alvarez-Melcon AC. Efficacy of the myofascial approach as a manual therapy technique in patients with clinical anxiety: A randomized controlled clinical trial. Complement Ther Clin Pract. 2023 May;51:101753. doi: 10.1016/j.ctcp.2023.101753. Epub 2023 Mar 29.
PMID: 37004342DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rodrigo Gozalo Pascual, PT
Universidad Complutense de Madrid
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Patients will be assigned to two groups: * Experimental group: who will receive myofascial intervention * Control / placebo group: who will receive sham myofascial intervention Neither the participants assigned to the groups nor the evaluators who measure the variables know to which group the subjects belong. Participants will be randomly assigned through the GraphPad software.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physical / Manual Therapist (PT, PhD Student), Biomechanics Professor
Study Record Dates
First Submitted
March 25, 2021
First Posted
April 1, 2021
Study Start
April 20, 2021
Primary Completion
July 29, 2022
Study Completion
July 29, 2022
Last Updated
August 2, 2022
Record last verified: 2022-07